Pictet-Biotech HP
LU0190161025
Pictet-Biotech HP/ LU0190161025 /
| NAV3/22/2023 |
Chg.-4.3300 |
Type of yield |
Investment Focus |
Investment company |
| 460.0000EUR |
-0.93% |
reinvestment |
Equity
Worldwide
|
Pictet AM (EU) ▶ |
Investment goal
The sub-fund seeks capital growth by investing at least two-thirds of its total assets in the shares of particularly innovative companies operating in medical biotechnology. The investment universe is not restricted to a specific geographical zone. However, given the particularly innovative nature of the pharmaceutical industry in North America and Europe, the vast majority of investments will be made in this zone.
Master data
| Type of yield: |
reinvestment |
| Funds Category: |
Equity |
| Region: |
Worldwide |
| Branch: |
Sector Biotechnology |
| Benchmark: |
MSCI AC World |
| Business year start: |
10/1 |
| Last Distribution: |
- |
| Depository bank: |
Pictet & Cie (Europe) S.A. |
| Fund domicile: |
Luxembourg |
| Distribution permission: |
Austria, Germany, Switzerland, United Kingdom |
| Fund manager: |
T. Storni, M. Minonne, L. Haueter |
| Fund volume: |
1.5 bill.
USD
|
| Launch date: |
6/30/2004 |
| Investment focus: |
- |
Conditions
| Issue surcharge: |
5.00% |
| Max. Administration Fee: |
1.60% |
| Minimum investment: |
0.00 EUR |
| Deposit fees: |
0.30% |
| Redemption charge: |
3.00% |
| Ongoing charges (12/31/2021): |
2.05% |
| Key Investor Information: |
Download (Print version) |
Investment company
| Funds company: |
Pictet AM (EU) |
| Address: |
15, avenue J. F. Kennedy, 1855, Luxemburg |
| Country: |
Luxembourg |
| Internet: |
www.am.pictet/de/germany
|
Countries
| United States of America |
|
81.61% |
| Netherlands |
|
4.89% |
| Canada |
|
4.82% |
| Denmark |
|
2.65% |
| Cash |
|
2.61% |
| United Kingdom |
|
1.76% |
| China |
|
1.48% |
| Switzerland |
|
0.18% |
Branches
| Healthcare |
|
85.74% |
| IT/Telecommunication |
|
8.03% |
| Cash |
|
2.61% |
| Pharma/Biotechnology |
|
0.01% |
| Others |
|
3.61% |